CA Stock MarketDetailed Quotes

CTX Crescita Therapeutics Inc

Watchlist
  • 0.580
  • 0.0000.00%
15min DelayTrading Nov 1 16:00 ET
11.24MMarket Cap-3866P/E (TTM)

Crescita Therapeutics Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
575.31%547K
-82.26%378K
303.53%2.08M
88.22%-261K
-72.59%125K
1.25%81K
223.37%2.13M
36.13%-1.02M
-372.28%-2.22M
341.27%456K
Net income from continuing operations
-229.54%-926K
-129.30%-626K
-330.39%-1.99M
-112.73%-150K
-757.44%-1.28M
-659.46%-281K
42.41%-273K
178.01%862K
24.92%1.18M
121.67%195K
Operating gains losses
---2K
80.00%9K
-96.59%6K
-80.39%10K
-1,000.00%-9K
----
-58.33%5K
2,300.00%176K
--51K
--1K
Depreciation and amortization
-18.93%304K
2.67%385K
2.38%1.51M
0.53%379K
5.31%377K
1.35%375K
2.46%375K
6.67%1.47M
8.65%377K
2.29%358K
Asset impairment expenditure
-37.21%81K
62.79%70K
-16.73%438K
-12.71%158K
-36.47%108K
12.17%129K
-28.33%43K
19.55%526K
13.13%181K
6.25%170K
Remuneration paid in stock
-16.92%54K
-4.55%21K
-62.90%82K
-143.75%-21K
-23.81%16K
-14.47%65K
-71.05%22K
-18.75%221K
-60.98%48K
-46.15%21K
Deferred tax
--0
--0
199.56%456K
143.01%197K
--0
--93K
--166K
-577.08%-458K
---458K
--0
Other non cashItems
-328.57%-48K
-276.60%-177K
68.93%-32K
124.32%45K
-466.67%-51K
310.00%21K
-146.53%-47K
-239.19%-103K
-372.06%-185K
85.71%-9K
Change In working capital
437.69%1.08M
-62.17%696K
143.23%1.61M
74.20%-879K
445.00%966K
41.21%-321K
255.21%1.84M
-35.34%-3.72M
-55.00%-3.41M
-224.44%-280K
-Change in receivables
140.04%1.28M
-131.30%-601K
245.04%3.54M
88.57%-274K
2,822.00%1.36M
547.06%532K
1,423.81%1.92M
-16.41%-2.44M
-1.74%-2.4M
-111.85%-50K
-Change in inventory
6,700.00%66K
568.46%996K
48.48%-917K
52.87%-394K
-195.59%-671K
98.94%-1K
123.92%149K
-29.45%-1.78M
-416.67%-836K
78.21%-227K
-Change in payables and accrued expense
92.52%-75K
216.00%348K
-654.74%-1.29M
-50.55%-408K
1,866.67%424K
-177.84%-1M
-133.78%-300K
-76.64%232K
-179.38%-271K
-102.59%-24K
-Change in other current assets
-221.85%-184K
-166.20%-47K
-0.73%271K
103.09%197K
-804.76%-148K
439.29%151K
-44.09%71K
202.25%273K
1,177.78%97K
125.30%21K
Cash from discontinued investing activities
Operating cash flow
575.31%547K
-82.26%378K
303.53%2.08M
88.22%-261K
-72.59%125K
1.25%81K
223.37%2.13M
36.13%-1.02M
-372.28%-2.22M
341.27%456K
Investing cash flow
Cash flow from continuing investing activities
-912K
0
54.14%-133K
-41.89%-105K
-1,300.00%-28K
0
0
65.72%-290K
66.67%-74K
99.66%-2K
Net PPE purchase and sale
---912K
--0
41.92%-133K
-707.69%-105K
-1,300.00%-28K
--0
--0
33.82%-229K
94.14%-13K
97.53%-2K
Net business purchase and sale
----
----
--0
----
----
----
----
---61K
----
----
Cash from discontinued investing activities
Investing cash flow
---912K
--0
54.14%-133K
-41.89%-105K
-1,300.00%-28K
--0
--0
65.72%-290K
66.67%-74K
99.66%-2K
Financing cash flow
Cash flow from continuing financing activities
-56.44%-158K
-138.38%-236K
57.64%-782K
-16.74%-258K
-19.12%-324K
91.48%-101K
41.07%-99K
-269.20%-1.85M
-13.92%-221K
-161.54%-272K
Net issuance payments of debt
-8.91%-110K
-9.09%-108K
70.28%-408K
-6.06%-105K
-11.96%-103K
90.74%-101K
-8.79%-99K
-293.41%-1.37M
-11.24%-99K
-12.20%-92K
Net common stock issuance
---48K
---78K
8.39%-393K
-112.50%-153K
-33.33%-240K
--0
--0
-324.75%-429K
-30.91%-72K
-718.18%-180K
Proceeds from stock option exercised by employees
----
----
216.67%19K
--0
--19K
----
----
--6K
--0
--0
Net other financing activities
----
---50K
----
----
----
----
----
0.00%-50K
----
----
Cash from discontinued financing activities
Financing cash flow
-56.44%-158K
-138.38%-236K
57.64%-782K
-16.74%-258K
-19.12%-324K
91.48%-101K
41.07%-99K
-269.20%-1.85M
-13.92%-221K
-161.54%-272K
Net cash flow
Beginning cash position
-7.24%9.53M
13.92%9.39M
-27.30%8.24M
-6.68%10.02M
-2.63%10.23M
-12.49%10.28M
-27.30%8.24M
-20.66%11.33M
-12.24%10.74M
-19.73%10.5M
Current changes in cash
-2,515.00%-523K
-93.01%142K
136.79%1.16M
75.14%-624K
-224.73%-227K
98.43%-20K
355.61%2.03M
-7.24%-3.16M
-183.62%-2.51M
120.82%182K
Effect of exchange rate changes
113.79%4K
-20.00%4K
-122.22%-14K
-220.00%-12K
-59.26%22K
-185.29%-29K
114.29%5K
1,000.00%63K
150.00%10K
100.00%54K
End cash Position
-11.87%9.01M
-7.24%9.53M
13.92%9.39M
13.92%9.39M
-6.68%10.02M
-2.63%10.23M
-12.49%10.28M
-27.30%8.24M
-27.30%8.24M
-12.24%10.74M
Free cash from
-550.62%-365K
-82.26%378K
255.56%1.94M
83.57%-366K
-78.63%97K
191.01%81K
247.07%2.13M
35.72%-1.25M
-222.43%-2.23M
268.15%454K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 575.31%547K-82.26%378K303.53%2.08M88.22%-261K-72.59%125K1.25%81K223.37%2.13M36.13%-1.02M-372.28%-2.22M341.27%456K
Net income from continuing operations -229.54%-926K-129.30%-626K-330.39%-1.99M-112.73%-150K-757.44%-1.28M-659.46%-281K42.41%-273K178.01%862K24.92%1.18M121.67%195K
Operating gains losses ---2K80.00%9K-96.59%6K-80.39%10K-1,000.00%-9K-----58.33%5K2,300.00%176K--51K--1K
Depreciation and amortization -18.93%304K2.67%385K2.38%1.51M0.53%379K5.31%377K1.35%375K2.46%375K6.67%1.47M8.65%377K2.29%358K
Asset impairment expenditure -37.21%81K62.79%70K-16.73%438K-12.71%158K-36.47%108K12.17%129K-28.33%43K19.55%526K13.13%181K6.25%170K
Remuneration paid in stock -16.92%54K-4.55%21K-62.90%82K-143.75%-21K-23.81%16K-14.47%65K-71.05%22K-18.75%221K-60.98%48K-46.15%21K
Deferred tax --0--0199.56%456K143.01%197K--0--93K--166K-577.08%-458K---458K--0
Other non cashItems -328.57%-48K-276.60%-177K68.93%-32K124.32%45K-466.67%-51K310.00%21K-146.53%-47K-239.19%-103K-372.06%-185K85.71%-9K
Change In working capital 437.69%1.08M-62.17%696K143.23%1.61M74.20%-879K445.00%966K41.21%-321K255.21%1.84M-35.34%-3.72M-55.00%-3.41M-224.44%-280K
-Change in receivables 140.04%1.28M-131.30%-601K245.04%3.54M88.57%-274K2,822.00%1.36M547.06%532K1,423.81%1.92M-16.41%-2.44M-1.74%-2.4M-111.85%-50K
-Change in inventory 6,700.00%66K568.46%996K48.48%-917K52.87%-394K-195.59%-671K98.94%-1K123.92%149K-29.45%-1.78M-416.67%-836K78.21%-227K
-Change in payables and accrued expense 92.52%-75K216.00%348K-654.74%-1.29M-50.55%-408K1,866.67%424K-177.84%-1M-133.78%-300K-76.64%232K-179.38%-271K-102.59%-24K
-Change in other current assets -221.85%-184K-166.20%-47K-0.73%271K103.09%197K-804.76%-148K439.29%151K-44.09%71K202.25%273K1,177.78%97K125.30%21K
Cash from discontinued investing activities
Operating cash flow 575.31%547K-82.26%378K303.53%2.08M88.22%-261K-72.59%125K1.25%81K223.37%2.13M36.13%-1.02M-372.28%-2.22M341.27%456K
Investing cash flow
Cash flow from continuing investing activities -912K054.14%-133K-41.89%-105K-1,300.00%-28K0065.72%-290K66.67%-74K99.66%-2K
Net PPE purchase and sale ---912K--041.92%-133K-707.69%-105K-1,300.00%-28K--0--033.82%-229K94.14%-13K97.53%-2K
Net business purchase and sale ----------0-------------------61K--------
Cash from discontinued investing activities
Investing cash flow ---912K--054.14%-133K-41.89%-105K-1,300.00%-28K--0--065.72%-290K66.67%-74K99.66%-2K
Financing cash flow
Cash flow from continuing financing activities -56.44%-158K-138.38%-236K57.64%-782K-16.74%-258K-19.12%-324K91.48%-101K41.07%-99K-269.20%-1.85M-13.92%-221K-161.54%-272K
Net issuance payments of debt -8.91%-110K-9.09%-108K70.28%-408K-6.06%-105K-11.96%-103K90.74%-101K-8.79%-99K-293.41%-1.37M-11.24%-99K-12.20%-92K
Net common stock issuance ---48K---78K8.39%-393K-112.50%-153K-33.33%-240K--0--0-324.75%-429K-30.91%-72K-718.18%-180K
Proceeds from stock option exercised by employees --------216.67%19K--0--19K----------6K--0--0
Net other financing activities -------50K--------------------0.00%-50K--------
Cash from discontinued financing activities
Financing cash flow -56.44%-158K-138.38%-236K57.64%-782K-16.74%-258K-19.12%-324K91.48%-101K41.07%-99K-269.20%-1.85M-13.92%-221K-161.54%-272K
Net cash flow
Beginning cash position -7.24%9.53M13.92%9.39M-27.30%8.24M-6.68%10.02M-2.63%10.23M-12.49%10.28M-27.30%8.24M-20.66%11.33M-12.24%10.74M-19.73%10.5M
Current changes in cash -2,515.00%-523K-93.01%142K136.79%1.16M75.14%-624K-224.73%-227K98.43%-20K355.61%2.03M-7.24%-3.16M-183.62%-2.51M120.82%182K
Effect of exchange rate changes 113.79%4K-20.00%4K-122.22%-14K-220.00%-12K-59.26%22K-185.29%-29K114.29%5K1,000.00%63K150.00%10K100.00%54K
End cash Position -11.87%9.01M-7.24%9.53M13.92%9.39M13.92%9.39M-6.68%10.02M-2.63%10.23M-12.49%10.28M-27.30%8.24M-27.30%8.24M-12.24%10.74M
Free cash from -550.62%-365K-82.26%378K255.56%1.94M83.57%-366K-78.63%97K191.01%81K247.07%2.13M35.72%-1.25M-222.43%-2.23M268.15%454K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data